CHI3L1 and myeloid sarcoma: Immunohistochemical studies have identified CHI3L1 immunopositivity in astrocytes and macrophages/microglia in MS brain tissue, particularly in active and chronic active white matter (WM) lesions (Cubas-Núñez et al., 2021; Hinsinger et al., 2015).